Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic reprogramming of immune cells in pancreatic cancer progression
Hong Xiang, Runjuan Yang, Jiaxin Tu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 113992-113992
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

The impact of lipid metabolism on breast cancer: a review about its role in tumorigenesis and immune escape
Diandra Zipinotti dos Santos, Josiany Carlos de Souza, Tatiana Massariol Pimenta, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 51
Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review
Nilesh Kumar Sharma, Anjali Bahot, Gopinath Sekar, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 680-680
Open Access | Times Cited: 13
Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma
Shailendra K. Gautam, Surinder K. Batra, Maneesh Jain
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 35
Reprogramming of Treg cells in the inflammatory microenvironment during immunotherapy: a literature review
Xinyan Wu, Zhigang Zhou, Qiang Cao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 31
Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment
Haixia Zhang, Shizhen Li, Dan Wang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 9
Analyzing the impact of metabolism on immune cells in tumor microenvironment to promote the development of immunotherapy
Yanru Long, Houhui Shi, Yuedong He, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 6
The roles and molecular mechanisms of non-coding RNA in cancer metabolic reprogramming
Shizhen Li, Mingjing Peng, Shiming Tan, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Tumour‐associated neutrophils: Potential therapeutic targets in pancreatic cancer immunotherapy
Qihang Wu, Han Mao, Zhengting Jiang, et al.
Immunology (2024) Vol. 172, Iss. 3, pp. 343-361
Closed Access | Times Cited: 5
FOXA1/UBE2T Inhibits CD8+T Cell Activity by Inducing Mediates Glycolysis in Lung Adenocarcinoma
Jiangtao Pu, Dengguo Zhang, Biao Wang, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 4, pp. 134-134
Open Access | Times Cited: 5
The success of the tumor immunotherapy: neutrophils from bench to beside
Meng Zhu, Ru Jia, Xiaojie Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Personalized medicine in pancreatic cancer: Harnessing the potential of mRNA vaccines
Aariz Hussain, Areeba Fareed
Journal of Genetic Engineering and Biotechnology (2025) Vol. 23, Iss. 1, pp. 100469-100469
Closed Access
Overcoming the limitations of immunotherapy in pancreatic ductal adenocarcinoma: Combining radiotherapy and metabolic targeting therapy
Han Zhang, Wenjin Xu, Haitao Zhu, et al.
Journal of Cancer (2024) Vol. 15, Iss. 7, pp. 2003-2023
Open Access | Times Cited: 4
Recent advances in sonodynamic therapy strategies for pancreatic cancer
Peng Cheng, Shuai Ming, Wei Cao, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 1
Closed Access | Times Cited: 4
Steatosis in metabolic diseases: A focus on lipolysis and lipophagy
Xingtao Zhao, Felix Kwame Amevor, Zhifu Cui, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114311-114311
Open Access | Times Cited: 11
Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions
Dhana Sekhar Reddy Bandi, Sujith Sarvesh, Batoul Farran, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 71-72, pp. 26-39
Closed Access | Times Cited: 11
Metabolomics analyses reveal the crucial role of ERK in regulating metabolic pathways associated with the proliferation of human cutaneous T‐cell lymphoma cells treated with Glabridin
Abdul Q. Khan, Maha Victor Agha, Fareed Ahmad, et al.
Cell Proliferation (2024) Vol. 57, Iss. 9
Open Access | Times Cited: 3
Metformin induces tumor immunogenic cell death in ovarian cancer by activating AMPK pathway
Yixiong Chen, Lufang Wang, Na Chen, et al.
Translational Oncology (2024) Vol. 47, pp. 102052-102052
Open Access | Times Cited: 3
β2-Adrenergic Receptor Mediated Inhibition of T Cell Function and Its Implications for CAR-T Cell Therapy
Muhammad Asad Farooq, Iqra Ajmal, Xinhui Hui, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12837-12837
Open Access | Times Cited: 9
IPIAD- an augmentation regimen added to standard treatment of pancreatic ductal adenocarcinoma using already-marketed repurposed drugs irbesartan, pyrimethamine, itraconazole, azithromycin, and dapsone
Richard E. Kast
Oncoscience (2024) Vol. 11, pp. 15-31
Open Access | Times Cited: 2
Apolipoprotein E is a prognostic factor for pancreatic cancer and associates with immune infiltration
Bin Wu, Xiaodan Yang, Fei Chen, et al.
Cytokine (2024) Vol. 179, pp. 156628-156628
Closed Access | Times Cited: 2
Genetically predicted blood metabolites mediate the association between circulating immune cells and pancreatic cancer: A Mendelian randomization study
Zhao Guo, Yuanting Cai, Yuning Wang, et al.
The Journal of Gene Medicine (2024) Vol. 26, Iss. 5
Closed Access | Times Cited: 2
Arsenic activated GLUT1-mTORC1/HIF-1α-PKM2 positive feedback networks promote proliferation and migration of bladder epithelial cells
Zhushan Fu, Meiqi Deng, Qing Zhou, et al.
The Science of The Total Environment (2024) Vol. 947, pp. 174538-174538
Closed Access | Times Cited: 2
Changes in Pancreatic Senescence Mediate Pancreatic Diseases
Kailin Li, Ji Bian, Yao Xiao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3513-3513
Open Access | Times Cited: 7
FAM53B promotes pancreatic ductal adenocarcinoma metastasis by regulating macrophage M2 polarization
Xuan-Zeng Pei, Min Cai, Dawei Jiang, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 4, pp. 1479-1499
Open Access | Times Cited: 1
The crosstalk between metabolic reprogramming and epithelial-mesenchymal transition and their synergistic roles in distant metastasis in breast cancer
Liyan Yu, Yongni Chen, Yingyu Chen, et al.
Medicine (2024) Vol. 103, Iss. 24, pp. e38462-e38462
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top